Progress in cancer nanotechnology

Progress in Molecular Biology and Translational Science

Volumn 95, Issue C, 2010, Pages 193-236

  Majoros, Istvan J ^a   Ward, Brent B ^b   Lee, Kyung Hoon ^a,c   Choi, Seok Ki ^a   Huang, Baohua ^a   Myc, Andrzej ^a   Baker, James R ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN HOSPITALS   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 78649238956     PISSN: 18771173     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-385071-3.00008-3     Document Type: Chapter

References (171)

1. NIH Roadmap for Medical research
2. NIH/NCI U. S. D. o. h. a. h. s. Cancer nanotechnology: going small for big advances 2004
3. M. Ferrari Cancer nanotechnology: opportunities and challenges Nature 5 2005 161 171
4. T.O. Pangburn, M.A. Petersen, B. Waybrant, M.M. Adil, and E. Kokkoli Peptide- and aptamer-functionalized nanovectors for targeted delivery of therapeutics J Biomed Eng 131 2009 1 20
5. O.P. Medina, Y. Zhu, and K. Kairemo Targeted liposomal drug delivery in cancer Curr Pharm Des 10 2004 2981 2989
6. G. Orive, R.M. Hernandez, A.R. Gascon, and J.L. Pedrax Micro and nano drug delivery systems in cancer therapy Cancer Ther 3 2005 131 138
7. S.S. Suri, H. Fenniri, and B. Singh Nanotechnology-based drug delivery systems J Occup Med Toxicol 2 2007 1 6
8. G.A. Hughes Nanostructure-mediated drug delivery Nanomedicine 1 2004 22 30
9. P. Tian Molecular dynamics simulations of nanoparticles Annual Rep Prog Chem Sect C 104 2008 142 164
10. D. Lu, A. Aksimentiev, A.Y. Shih, E. Cruz-Chu, P.L. Freddolino, and A. Arkhipov The role of molecular modeling in bionanotechnology Phys Biol 3 2006 S40 S53
11. P. Tian Molecular dynamics simulations of nanoparticles Annu Rep Prog Chem Sect C 104 2008 142 164
12. N. Haddish-Berhane, J.L. Rickus, and K. Haghighi The role of multiscale computational approaches for rational design of conventional and nanoparticle oral drug delivery systems Int J Nanomedicine 2 2007 315 331
13. D.E. Discher, V. Ortiz, G. Srinivas, M.L. Klein, Y. Kim, and D. Christian Emerging applications of polymersomes in delivery: from molecular dynamics to shrinkage of tumors Prog Polym Sci 32 2007 838 857
14. D. Hanahan, and R.A. Weinberg The hallmarks of cancer Cell 100 2000 57 70
15. S.K. Kandasamy, H. Lee, and R.G. Larson Computational simulations of dendrimers 2009 Pan Stanford Chicago
16. G. Giupponi, M.A. Buzza, and D.B. Adolf Are polyelectrolyte dendrimers stimuli responsive? Macromolecules 40 2007 5959 5965
17. G. Nisato, R. Ivkov, and E.J. Amis Size invariance of polyelectrolyte dendrimers Macromolecules 33 2000 4172 4176
18. M. Ballauff, and C.N. Likos Dendrimers in solution: Insight from theory and simulation Angew Chem Int Ed 43 2004 2998 3020
19. A.M. Naylor, and W.A. Goddard III Starburst dendrimers. 5. Molecular shape control J Am Chem Soc 111 1989 2339 2341
20. I. Lee, B.D. Athey, A.W. Wetzel, W. Meizner, and J.R. Baker Jr. Structural molecular dynamics studies on polyamidoamine dendrimers for a therapeutic application: effects of pH and generation Macromolecules 35 2002 4510 4520
21. Y. Liu, V.S. Bryantsev, M.S. Diallo, and W.A. Goddard III PAMAM dendrimers undergo pH responsive conformational changes without swelling J Am Chem Soc 131 2009 2798 2799
22. P. Welch, and M. Muthukumar Tuning the density profile of dendrite polyelectrolytes Macromolecules 31 1998 5892 5897
23. P.K. Maiti, T. Cagin, S.-T. Lin, and W.A. Goddard III Effect of solvent and pH on the structure of PAMAM dendrimers Macromolecules 38 2005 979 991
24. R. Blaak, S. Lehmann, and C.N. Likos Charge-induced conformational changes of dendrimers Macromolecules 41 2008 4452 4458
25. I. Tanis, and K. Karatasos Molecular dynamics simulations of polyamidoamine dendrimers and their complexes with linear poly(ethylene oxide) at different pH conditions: static properties and hydrogen bonding Phys Chem Chem Phys 11 2009 10017 10028
26. A. Quintana, E. Raczka, L. Piehler, I. Lee, A. Myc, and I.J. Majoros Design and function of a dendrimer-based therapeutic nanodevice targeted to tumor cells through the folate receptor Pharm Res 19 2002 1310 1316
27. X. Shi, S. Wang, S. Meshinchi, M.E.V. Antwerp, X. Bi, and I. Lee Dendrimer-entrapped gold nanoparticles as a platform for cancer-cell targeting and imaging Small 3 2007 1245 1252
28. X. Shi, I. Lee, and J.R. Baker Jr. Acetylation of dendrimer-entropped gold and silver nanoparticles J Mater Chem 18 2008 586 593
29. X. Shi, S.H. Wang, I. Lee, M. Shen, and J.R. Baker Jr. Comparison of the interalization of targeted dendrimers and dendrimer-entrapped gold nanoparticles into cancer cells Biopolymers 91 2009 936 942
30. S.K. Kandasamy, H. Lee, and R.G. Larson Computational simulations of dendrimers I.J. Majoros, J.R. Baker Jr. Dendrimer-based nanomedicine 2009 Pan Stanford Chicago
31. H. Lee, and R.G. Larson Coarse-grained molecular dynamics studies of the concentration and size dependence of fifth- and seventh-generation PAMAMA dendrimers on pore fomration in DMPC bilayer J. Phys Chem B 112 2008 7778 7784
32. C.V. Kelly, P.R. Leroueil, B.G. Orr, M.M. Banaszak Holl, and I. Andricioaei Poly(amidoamine) dendrimers on lipid bilayers. II: Effects of bilayer phase and dendrimer termination J Phys Chem B 112 2008 9346 9353
33. H. Lee, and R.G. Larson Coarse-grained molecular dynamics studies of the concentration and size dependence of fifth- and seventh-generation PAMAM dendrimers on pore formation in DMPC bilayer J Phys Chem B 112 2008 7778 7784
34. H. Lee, and R.G. Larson Molecular dynamics simulations of PAMAM dendrimer-induced pore for mation in DPPC bilayers with a coarse-graned model J Phys Chem B 110 2006 18304 18311
35. T.-X. Xiang, and B.D. Anderson Liposomal drug transport: a molecular perspective form molecular dynamics simulations in lipid bilayers Adv Drug Deliv Rev 58 2006 1357 1378
36. S.-J. Marrink, and H.J.C. Berendsen Simulation of water transport through a lipid membrane J Phys Chem B 98 1994 4155 4168
37. K. Tu, D.J. Tobias, J.K. Blasie, and M.L. Klein Molecular dynamics investigation of the structure of a fully hydrated gel-phase dipalmitoylphosphatidylcholine bilayer Biophys J 70 1996 595 608
38. R.M. Venable, B.R. Brooks, and R.W. Pator Molecular dynamics simulations of gel (LB1) phase lipid bilayers in conatant and constant surface area ensembles J. Phys Chem B 112 2000 4822 4832
39. R.G. Snyder, K. Tu, M.L. Klein, R. Mendelssohn, H.L. Strauss, and W. Sun Acyl chain conformation and packing in dipalmotoylphosphatidylcholine bilayers from MD simulation and IR spectroscopy J Phys Chem B 106 2002 6273 6288
40. M. Prato, K. Kosstarelos, and A. Blanco Functionalized carbon nanotubes in drug design and discovery Acc Chem Res 41 2008 60 68
41. Z. Liu, K. Chen, C. Davis, S. Sherlock, Q. Cao, and X. Chen Drug delivery with carbon nanotubes for in vivo cancer treatment Cancer Res 68 2008 6652 6660
42. T.A. Hilder, and J.M. Hill Modeling the encapsulation of the anticancer drug cisplatin into carbon nanotubes Nanotechnology 18 2007 1 8
43. X. Shi, Y. Kong, and H. Gao Coarse grained molecular dynamics and theoretical studies of carbon nanotubes entering cell membranes Acta Mech Sin 24 2008 161 169
44. J. Kukowska-Latallo, K.A. Candido, Z. Cao, S.S. Nigavekar, I.J. Majoros, and T.P. Thomas Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer Cancer Res 65 2005 5317 5324
45. I.J. Majoros, J.R. Baker Jr. Dendrimer-based nanomedicine 2008 Pan Stanford Publishing Pte Ltd. Singapore
46. R. Langer Biomaterials in drug delivery and tissue engineering: one laboratory's experience Acc Chem Res 33 2000 :94101.
47. I.J. Majoros, C.B. Mehta, and J.R. Baker Jr. Mathematical description of dendrimer structure J Comput Theor Nanosci 1 2004 193 198
48. K.E. Uhrich, S.M. Cannizzaro, R. Langer, and K.M. Shakesheff Polymeric systems for controlled drug release Chem Rev 99 1999 3181 3198
49. N. Kumar, R.S. Langer, and A.J. Domb Polyanhydrides: an overview Adv Drug Deliv Rev 54 2002 889 910
50. C. Allen, Y. Yu, D. Maysinger, and A. Eisenburg Polycaprolactone-b- poly(ethylene oxide) block copolymermicelles as a novel drug delivery vehicle for neurotrophic agent FK506 and L-685, 818 Bioconj Chem 9 1998 564 572
51. M.S. Jhaveri, A. Rait, K.-M. Chung, J.B. Trepel, and E.H. Chang Antisense oligonucleotides targeted to human alpha folate receptor inhibit breast cancer cell growth and sensitize the cells to doxorubicin treatment Mol Cancer Ther 3 2004 1505 1512
52. W. Yu, K.F. Pirollo, A. Rait, B. Yu, L.M. Xiang, and W.Q. Huang A sterically stabilized immunolipoplex for systemic administration of a therapeutic gene Gene Ther 11 2004 1434 1440
53. L. Xu, K.F. Pirollo, and E.H. Chang Tumor-targeted p53-gene therapy enhances the efficacy of conventional chemo/radiotherapy J Control Release 74 2001 115 128
54. S. Foley, C. Crowley, M. Smaihi, C. Bonfils, B. Erlanger, and P. Seta Biochem Biophys Res Commun 294 2002 116 119
55. J. Ashcroft, D. Tsyboulski, K. Hartman, and T. Zakharian Fullerene (C60) immunoconjugates: interaction of water-soluble C60 derivatives with the murine anti-gp240 melanoma antibody Chem Commun 28 2006 3004 3006
56. J. Yang, K. Wang, J. Driver, J. Yang, and A. Barron The use of fullerene substituted phenylalanine amino acid as a passport for peptides through cell membranes Org Biomol Chem 5 2007 260 266
57. Z. Zhang, X. Yang, Y. Zhang, B. Zeng, S. Wang, and T. Zhu Delivery of telomerase reverse transcriptase small interfering RNA in complex with positively charged single-walled carbon nanotubes suppresses tumor growth Clin Cancer Res 2 2006 4933 4939
58. C.Y. Zhang, H. Yeh, M. Kuroki, and T. Wang Single-quantum-dot based DNA nanosensor Nat Mater 4 2005 826 831
59. J.A. Kloepfer, R.E. Mielke, M.S. Wong, K.H. Nealson, G. Stucky, and J.L. Nadeau Quantum dots as strain- and metabolism-specific microbiological labels Appl Environ Microbiol 69 2003 4205 4213
60. J.M. Ness, R.S. Akhtar, C.B. Latham, and K.A. Roth Combined tyramide signal amplification and quantum dots for sensitive and photostable immuno-fluorescence detection J Histochem Cytochem 51 2003 981 987
61. X. Wu, H. Liu, K.N. Haley, J.A. Treadway, J.P. Larson, and N. Ge Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots Nat Biotechnol 21 2003 41 46
62. H. Tada, H. Higuchi, T. Wanatabe, and N. Ohuchi In vivo real-time tracking of single quantum dots conjugated with monoclonal anti-HER2 antibody in tumors of mice Cancer Res 67 2007 1138 1144
63. X. Huang, I.H. El-Sayed, W. Qian, and M.A. El-Sayed Cancer cell imaging and photothermal therapy in the near-infared region by using gold nanorods J Am Chem Soc 128 2006 2115 2120
64. W.D. James, L.R. Hirsch, J.L. West, P.D. Neal, and J.D. Payne Application of INAA to the build-up and clearance of gold nanoshells in clinical studies in mice J Radioanal Nucl Chem 271 2007 455 459
65. I. Ojima Guided molecular missiles for tumor-targeting chemotherapy; case studies using the second-generation taxoids as warheads Acc Chem Res 41 2008 108 111
66. I.J. Majoros, C.R. Williams, and J.R. Baker Jr. Current dendrimer applications in cancer diagnosis and therapy Curr Top Med Chem 8 2008 1165 1179
67. R.P. Feazell, N. Nakayama-Ratchford, H. Dai, and S.J. Lippard Soluble single-walled carbon nanotubes as longboat delivery systems for platinum(IV) anticancer drug design J Am Chem Soc 129 2007 8438 8439
68. G.M. Dubowchik, and M.A. Walker Receptor-mediated and enzyme-dependent targeting of cytotoxic anticancer drugs Pharmcol Ther 83 1999 67 123
69. J.E. Dancey, and H.X. Chen Strategies for optimizing combinations of moleuclarly targeted anticancer agents Nat Rev Drug Discovery 5 2006 649 659
70. I.J. Majoros, A. Myc, T. Thomas, C.B. Mehta, and J.R. Baker PAMAM dendrimer-based multifunctional conjugate for cancer therapy: synthesis, characterization, and functionality Biomacromolecules 7 2006 572 579
71. T.P. Thomas, I.J. Majoros, A. Kotlyar, J.F. Kukowska-Latallo, A. Bielinska, and A. Myc Targeting and inhibition of cell growth by an engineered dendritic nanodevice J Med Chem 48 2005 3729 3735
72. P.C. Nowell The clonal evolution of tumor cell populations Science 194 1976 23 28
73. I.J. Majoros, T.P. Thomas, C.B. Mehta, and J.R. Baker Poly(amidoamine) dendrimer-based multifunctional engineered nanodevice for cancer therapy J Med Chem 48 2005 5892 5899
74. T. Etrych, T. Mrkvan, B. Rihova, and K. Ulbrich Star-shaped immunoglobulin-containing HPMA-based conjugates with doxorubicin for cancer therapy J Control Release 122 2007 31 38
75. L.M. Bareford, and P.W. Swaan Endocytic mechanisms for targeted drug delivery Adv Drug Deliv Rev 59 2007 748 758
76. G.M. Dubowchik, and M.A. Walker Receptor-mediated and enzyme-dependent targeting of cytotoxic anticancer drugs Pharmacol Ther 83 1999 67 123
77. A. Joshi, D. Vance, P. Rai, A. Thiyagarajan, and R.S. Kane The design of polyvalent therapeutics Chem Eur J 14 2008 7738 7747
78. A.R. Hilgenbrink, and P.S. Low Folate receptor-mediated drug targeting: from therapeutics to diagnostics J Pharm Sci 94 2005 2135 2146
79. R.J. Lee, and P.S. Low Folate-mediated tumor cell targeting of liposome-entrapped doxorubicin in vitro Biochim Biophys ActaBiomembr 1233 1995 134 144
80. X. Montet, M. Funovics, K. Montet-Abou, R. Weissleder, and L. Josephson Multivalent effects of RGD peptides obtained by nanoparticle display J Med Chem 49 2006 6087 6093
81. R. Shukla, T.P. Thomas, J. Peters, A. Kotlyar, A. Myc, and J.R. Baker Jr. Tumor angiogenic vasculature targeting with PAMAM dendrimer-RGD conjugates Chem Commun 2005 5739 5741
82. K. Temming, M. Lacombe, R.Q.J. Schaapveld, L. Orfi, G. Kri, and K. Poelstra Rational design of RGD-albumin conjugates for targeted delivery of the VEGF-R kinase inhibitor PTK787 to angiogenic endothelium ChemMedChem 1 2006 1200 1203
83. Y. Chen, C.A. Foss, Y. Byun, S. Nimmagadda, M. Pullambhatla, and J.J. Fox Radiohalogenated prostate-specific membrane antigen (PSMA)-based ureas as imaging agents for prostate cancer J Med Chem 51 2008 7933 7943
84. Z.M. Qian, H. Li, H. Sun, and K. Ho Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway Pharmacol Rev 54 2002 561 587
85. R. Shukla, T.P. Thomas, A.M. Desai, A. Kotlyar, S.J. Park, and J.R. Baker Jr. HER2 specific delivery of methotrexate by dendrimer conjugated anti-HER2mAb Nanotechnology 19 2008 295102
86. R. Shukla, T.P. Thomas, A.M. Desai, A. Kotlyar, S.J. Park, and J.R. Baker Jr. HER2 specific delivery of methotrexate by dendrimer conjugated anti-HER2 mAb Nanotechnology 19 2008 295102
87. T.P. Thomas, R. Shukla, A. Kotlyar, B. Liang, J.Y. Ye, and T.B. Norris Dendrimer-epidermal growth factor conjugate displays superagonist activity Biomacromolecules 9 2008 603 609
88. Y.C. Lee, and R.T. Lee Carbohydrate-protein interactions: basis of glycobiology Acc Chem Res 28 1995 321 327
89. L.L. Kiessling, J.E. Gestwicki, and L.E. Strong Synthetic multivalent ligands in the exploration of cell-surface interactions Curr Opin Chem Biol 4 2000 696 703
90. M. Mammen, S.K. Choi, and G.M. Whitesides Polyvalent interactions in biological systems: implications for design and use of multivalent ligands and inhibitors Angew Chem Int Ed 37 1998 2755
91. R. Roy Syntheses and some applications of chemically defined multivalent glycoconjugates Curr Opin Struct Biol 6 1996 692 702
92. Y. Choi, T. Thomas, A. Kotlyar, M.T. Islam, and J.J.R. Baker Synthesis and functional evaluation of DNA-assembled polyamidoamine dendrimer clusters for cancer cell-specific targeting Chem Biol 12 2005 35 43
93. Y. Lu, and P.S. Low Folate-mediated delivery of macromolecular anticancer therapeutic agents Adv Drug Deliv Rev 54 2002 675 693
94. J.R. Schnell, H.J. Dyson, and P.E. Wright Strcuture, dynamics, and catalytic function of dihydrofolate Annu Rev Biophys Biomol Struct 33 2004 119 140
95. S. Chunduru, V. Cody, J. Luft, W. Pangborn, J. Appleman, and R. Blakley Methotrexate-resistant variants of human dihydrofolate reductase. Effects of Phe31 substitutions J Biol Chem 269 1994 9547 9555
96. M.H. Tattersall, B. Brown, and E. Frei 3rd The reversal of methotrexate toxicity by thymidine with maintenance of antitumour effects Nature 253 1975 198 200
97. A. Myc, I.J. Majoros, T.P. Thomas, and J.R. Baker Dendrimer-based targeted delivery of an apoptotic sensor in cancer cells Biomacromolecules 8 2007 13 18
98. L.M. Kaminskas, B.D. Kelly, V.M. McLeod, B.J. Boyd, G.Y. Krippner, and E.D. Williams Pharmacokinetics and tumor disposition of PEGylated, methotrexate conjugated Poly-l-lysine dendrimers Mol Pharm 6 2009 1190 1204
99. G. Wu, R.F. Barth, W. Yang, S. Kawabata, L. Zhang, and K. Green-Church Targeted delivery of methotrexate to epidermal growth factor receptor-positive brain tumors by means of cetuximab (IMC-C225) dendrimer bioconjugates Mol Cancer Ther 5 2006 52 59
100. Y. Chau, N.M. Dang, F.E. Tan, and R. Langer Investigation of targeting mechanism of new dextran-peptide-methotrexate conjugates using biodistribution study in matrix-metalloproteinase-overexpressing tumor xenograft model J Pharm Sci 95 2006 542 551
101. K.B. Bai, O. Lang, E. Orban, R. Szabo, L. Kohidai, and F. Hudecz Design, synthesis, and in vivo activity of novel drug delivery systems containing tufsin derivatives and methotrexate Bioconjug Chem 19 2008 2260 2269
102. J. Han, S.-J. Lim, M.-K. Lee, and C.-K. Kim Altered pharmacokinetics and liver targetability of methotrexate by conjugation with lactosylated albumins Drug Deliv 8 2001 125 134
103. N. Kohler, C. Sun, J. Wang, and M. Zhang Methotrexate-modified superparamagnetic nanoparticles and their intracellular uptake into human cancer cells Langmuir 21 2005 8858 8864
104. K.B. Bai, O. Lng, E. Orbn, R. Szab, L. Khidai, and F. Hudecz Design, synthesis, and in vitro activity of novel drug delivery systems containing tuftsin derivatives and methotrexate Bioconjug Chem 19 2008 2260 2269
105. B.A. Kamen, and A. Capdevila Receptor-mediated folate accumulation is regulated by the cellular folate content Proc Natl Acad Sci USA 83 1986 5983 5987
106. D.A. Tomalia, A.M. Naylor, and W.A. Goddard III Starburst dendrimers: molecular-level control of size, shape, surface chemistry, topology, and flexibility from atoms to macroscopic matter Angew Chem Int Ed 29 1990 138 175
107. P.B. Schiff, J. Fant, and S.B. Horwitz Promotion of microtubule assembly in vitro by taxol Nature 277 1979 665 667
108. F. Gueritte-Voegelein, D. Guenard, F. Lavelle, M.T. Le Goff, L. Mangatal, and P. Potier Relationships between the structure of taxol analogs and their antimitotic activity J Med Chem 34 1991 992 998
109. X. Wang, J. Li, Y. Wang, K.J. Cho, G. Kim, and A. Gjyrezi HFT-T, a targeting nanoparticle, enhances specific delivery of pacliltaxel to folate receptor-positive tumors ACS Nano 3 2009 3165 3174
110. Y.-S. Lin, R. Tungpradit, S. Sinchaikul, F.-M. An, D.-Z. Liu, and S. Phutrakul Targeting the deliver of glycan-based paclitaxel prodrugs to cancer cells via glucose transporters J Med Chem 51 2008 7428 7441
111. J. Pan, and S.-S. Feng Targeted delivery of paclitaxel using folate-decorated poly(lactide)-vitamin E TPGS nanoparticles Biomaterials 29 2008 2663 2672
112. H.-F. Liang, S.-C. Chen, M.-C. Chen, P.-W. Lee, C.-T. Chen, and H.-W. Sung Paclitaxel-loaded poly(I3-glutamic acid)-poly(lactide) nanoparticles as a targeted drug delivery system against cultured HepG2 cells Bioconjug Chem 17 2006 291 299
113. M. Cirilli, F. Bachechi, G. Ughetto, F.P. Colonna, and M.L. Capobianco Interactions between morpholinyl anthracyclines and DNA: the crystal structure of a morpholino doxorubicin bound to d(CGTACG) J Mol Biol 230 1993 878 889
114. S.K. Choi, T. Thomas, M. Li, A. Kotlyar, A.M. Desai, and J.R. Baker Jr. Light-controlled release of caged doxorubicin from folate receptor-targeting PAMAM dendrimer nanoconjugates Chem Commun 46 2010 2632 2634
115. L. Fan, F. Li, H. Zhang, Y. Wang, C. Cheng, and X. Li Co-delivery of PDTC and doxorubicin by multifunctional micellar nanoparticles to achieve active targeted drug deliverty and overcome multidrug resistance Biomaterials 31 2010 5634 5642
116. C. Grange, S. Geninatti-Crich, G. Esposito, D. Alberti, L. Tei, and B. Bussolati Combined delivery and magnetic resonance imaging of neural cell adhesion molecule-targeted doxorubicin-containing liposomes in experimentally induced Kaposi's sarcoma Cancer Res 70 2010 2180 2190
117. Y.-F. Zhang, J.-C. Wang, D.-Y. Bian, X. Zhang, and Q. Zhang Targeted delivery of RGD-modified liposomes encapsulating both combretastatin A-4 and doxorubicin for tumor therapy: In vitro and in vivo studies Eur J Pharm Biopharm 74 2010 467 473
118. L. Zhang, J. Xia, Q. Zhao, L. Liu, and Z. Zhang Functional graphene oxide as a nanocarrier for controlled loading and targeted delivery of mixed anticancer drugs Small 6 2010 537 544
119. X.-B. Xiong, Z. Ma, R. Lai, and A. Lavasanifar The therapeutic response to multifunctional polymeric nano-conjugates in the targeted cellular and subcellular delivery of doxurubicin Biomaterials 31 2010 757 768
120. S. Zhong, S. Bhattacharya, W. Chan, B. Jasti, and X. Li Leucine-aspartic acid-valine sequence as targeting ligand and drug carrier for doxurubicin delivery to melanoma cells: In vitro cellular uptake and cytotoxicity studies Pharm Res 26 2009 2578 2587
121. S. Dhar, Z. Liu, J. Thomale, H. Dai, and S.J. Lippard Targeted single-wall carbon nanotube-mediated Pt(IV) prodrug delivery using folate as a homing device J Am Chem Soc 130 2008 11467 11476
122. S. Dhar, F.X. Gu, R. Langer, O.C. Farokhzad, and S.J. Lippard Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles Proc Natl Acad Sci USA 105 2008 17356 17361
123. R.J. Lee, S. Wang, and P.S. Low Measurement of endosome pH following folate receptor-mediated endocytosis Biochim Biophys ActaMol Cell Res 1312 1996 237 242
124. J. Yang, H. Chen, I.R. Vlahov, J.-X. Cheng, and P.S. Low Characterization of the pH of folate receptor-containing endosomes and the rate of hydrolysis of internalized acid-labile folate-drug conjugates J Pharmacol Exp Ther 321 2007 462 468
125. M.S.K. Sutherland, R.J. Sanderson, K.A. Gordon, J. Andreyka, C.G. Cerveny, and C. Yu Lysosomal trafficking and cysteine protease metabolism confer target-specific cytotoxicity by peptide-linked anti-CD30-auristatin conjugates J Biol Chem 281 2006 10540 10547
126. T.P. Thomas, and J.R. Kukowska-Latallo I.J. Majoros, J.R. Baker Jr. Dendrimer-based nanomedicine 2008 Pan Stanford Hackensack 175 207
127. T. Etrych, T. Mrkvan, B. hov, and K. Ulbrich Star-shaped immunoglobulin-containing HPMA-based conjugates with doxorubicin for cancer therapy J Control Release 122 2007 31 38
128. A. Myc Preclinical antitumor efficacy evaluation of dendrimer-based methotrexate conjugates Anticancer Drugs 19 2008 143 149
129. S.K. Choi, T. Thomas, M. Li, A. Kotlyar, A. Desai, and J.R. Baker Jr. Light-controlled release of caged doxorubicin from folate receptor-targeting PAMAM dendrimer nanoconjugate Chem Commun 46 2010 2632 2634
130. P.-S. Lai, P.-J. Lou, C.-L. Peng, C.-L. Pai, W.-N. Yen, and M.-Y. Huang Doxorubicin delivery by polyamidoamine dendrimer conjugation and photochemical internalization for cancer therapy J Control Release 122 2007 39 46
131. Y. Lu, J. Wu, J. Wu, M. Gonit, X. Yang, and A. Lee Role of formulation composition in folate receptor-targeted liposomal doxorubicin delivery to acute myelogenous leukemia cells Mol Pharm 4 2007 707 712
132. X.Q. Pan, X. Zheng, G. Shi, H. Wang, M. Ratnam, and R.J. Lee Strategy for the treatment of acute myelogenous leukemia based on folate receptor beta-targeted liposomal doxorubicin combined with receptor induction using all-trans retinoic acid Blood 100 2002 594 602
133. R. Weissleder Scaling down imaging: molecular mapping of cancer in mice Nat Rev Cancer 2 2002 1 8
134. H. Maeda, J. Wu, T. Sawa, Y. Matsumura, and K. Hori Tumor vacular permeability and the EPR effect in macromolecular therapeutics: a review J Control Release 65 2000 271 284
135. H. Maeda The enhanced permeability and retention (EPR) effect in tumor vaculature: the key role of tumor-selective macromolecular drug targeting Adv Enzyme Regul 41 2001 189 207
136. C.C. Lee, E.R. Gillies, M.E. Fox, S.J. Guillaudeu, J.M.J. Frachet, and E.E. Dy A single dose of doxorubicin-functionalized bowtie dendrimer cures mice bearing C-26 colon carcinomas Proc Natl Acad Sci USA 103 2006 16649 16654
137. M. Kresse, S. Wagner, D. Pfefferer, R. Lawaczeck, V. Elate, and W. Semmler Targeting of ultrasmall superparamagnetic iron oxide (USPIO) particles to tumor cells in vivo by using tranferrin receptor pathways Magn Reson Med 40 1998 236 242
138. P. Wunderbaldinger, L.J. Josephson, and R. Weissleder Tat peptide directs enhanced clearance and hepatic permeability of magnetic nanoparticles Bioconjug Chem 13 2002 264 268
139. O.C. Farokhzad, S. Jon, A. Khademhosseini, T.N. Tran, D.A. Lavan, and R. Langer Nanoparticle-aptamer bioconjugates: a new approach for targeting prostate cancer cells Cancer Res 64 2004 7668 7672
140. J.K. Herr, J.E. Smith, C.D. Medley, D. Shangguan, and W. Tan Aptamer-conjuaged nanoparticles for selective collection and detection of cancer cells Anal Chem 78 2006 2918 2924
141. M.V. Yigit, D. Mazumdar, H.K. Kim, J.H. Lee, B. Odintsov, and Y. Lu Smart "turn-on" magnetic resonance contrast agents based on aptamer-functionalized superparamagnetic iron oxide nanoparticles ChemBioChem 8 2007 1675 1678
142. R. Weissleder, K. Kelly, E.Y. Sun, T. Shtatland, and L. Josephson Cell-specific targeting of nanoparticles by multivalent attachment of small molecules Nat Biotechnol 23 2005 1418 1423
143. Y. Zhang, Y. Sun, X. Xu, H. Zhu, L. Huang, and Y. Qi Synthesis, biodistribution, and microsingle photon emission computed tomography (SPECT) imaging study of technetium-99 m labeled PEGylated dendrimer poly(amidoamine) (PAMAM)-folic acid conjugates J Med Chem 53 2010 3262
144. S.D. Swanson, J.F. Kukowska-Latallo, A.K. Patri, C. Chen, S. Ge, and Z. Cao Int J Nanomedicine 3 2008 201
145. Z. Cheng, D.L.J. Thorek, and A. Tsurkas Gadolinium-conjugated dendrimer nanoclusters as a tumor-targeted TI magnetic resonance imaging contrast agent Angew Chem Int Ed 49 2010 346
146. R. Lauro, A. Platania, C. Liberatore, G. Reda, and C. Spinelli Biochemical profile of essential aterial hypertension. Indications for a targeted therapy: experience with propranolol Clin Ter 85 1978 19 25
147. L. Foulds Tumor progression Cancer Res 17 1957 355 366
148. E.S. Olson, T. Jiang, T.A. Aguilera, Q.T. Nguyen, L.G. Ellies, and M. Scadeng Activatable cell penetrating peptides linked to nanoparticles as dual probes for in vivo fluorescence and MR imaging of proteases PNAS 107 2010 4311
149. C.A. Boswell, P.K. Eck, C.A.S. Regino, M. Bernardo, K.J. Wang, and D.E. Milenic Synthesis, characterization, biological evaluation of integrin a nb 3-targeted PAMAM dendrimer Mol Pharm 5 2008 527 539
150. A.K. Patri, A. Myc, J. Beals, T.P. Thomas, N.H. Bander, and J.R. Baker Jr. Synthesis and in vitro testing of J591 antibody-dendrimer conjugates for targeted prostate cancer therapy Bioconjug Chem 15 2004 1174
151. J.F. Kerr, A.H. Wyllie, and A.R. Currie Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics Br J Cancer 26 1972 239 257
152. N. Zurgil, Y. Shafran, D. Fixler, and M. Deutsch Analysis of early apoptotic events in individual cells by fluorescence intensity and polarization measurements Biochem Biophys Res Commun 290 2002 1573 1582
153. E. Finkel The mitochondrion: is it central to apoptosis? Science 292 2001 624 626
154. D.R. Green, and J.C. Reed Mitochondria and apoptosis Science 281 1998 1309 1312
155. M. Demoy, T. Minko, P. Kopeckova, and J. Kopecek Time- and concentration-dependent apoptosis and necrosis induced by free and HPMA copolymer-bound doxorubicin in human ovarian carcinoma cells J Control Release 69 2000 185 196
156. K.M. Heiskanen, M.B. Bhat, H.W. Wang, J. Ma, and A.L. Nieminen Mitochondrial depolarization accompanies cytochrome c release during apoptosis in PC6 cells J Biol Chem 274 1999 5654 5658
157. A. Strebel, T. Harr, F. Bachmann, M. Wernli, and P. Erb Green fluorescent protein as a novel tool to measure apoptosis and necrosis Cytometry 43 2001 126 133
158. J. Liu, M. Bhalgat, C. Zhang, Z. Diwu, B. Hoyland, and D.H. Klaubert Fluorescent molecular probes V: a sensitive caspase-3 substrate for fluorometric assays Bioorg Med Chem Lett 9 1999 3231 3236
159. H. Hug, M. Los, W. Hirt, and K.M. Debatin Rhodamine 110-linked amino acids and peptides as substrates to measure caspase activity upon apoptosis induction in intact cells Biochemistry 38 1999 13906 13911
160. H.Z. Zhang, S. Kasibhatla, J. Guastella, B. Tseng, J. Drewe, and S.X. Cai N-Ac-DEVD-N′-(Polyfluorobenzoyl)-R110: novel cell-permeable fluorogenic caspase substrates for the detection of caspase activity and apoptosis Bioconjug Chem 14 2003 458 463
161. R. Sgonc, and J. Gruber Apoptosis detection: an overview Exp Gerontol 33 1998 525 533
162. L.F. Span, A.H. Pennings, G. Vierwinden, J.B. Boezeman, R.A. Raymakers, and T. de Witte The dynamic process of apoptosis analyzed by flow cytometry using Annexin-V/propidium iodide and a modified in situ end labeling technique Cytometry 47 2002 24 31
163. A.M. Steff, M. Fortin, C. Arguin, and P. Hugo Detection of a decrease in green fluorescent protein fluorescence for the monitoring of cell death: an assay amenable to high-throughput screening technologies Cytometry 45 2001 237 243
164. D.M. Finucane, E. Bossy-Wetzel, N.J. Waterhouse, T.G. Cotter, and D.R. Green Bax-induced caspase activation and apoptosis via cytochrome c release from mitochondria is inhibitable by Bcl-xL J Biol Chem 274 1999 2225 2233
165. K.J. Kelly, R.M. Sandoval, K.W. Dunn, B.A. Molitoris, and P.C. Dagher A novel method to determine specificity and sensitivity of the TUNEL reaction in the quantitation of apoptosis Am J Physiol Cell Physiol 284 2003 C1309 C1318
166. J. Liu, and Y. Lu FRET study of a trifluorophore-labeled DNAzyme J Am Chem Soc 124 2002 15208 15216
167. C. Berney, and G. Danuser FRET or no FRET: a quantitative comparison Biophys J 84 2003 3992 4010
168. S.R. Stauffer, and J.F. Hartwig Fluorescence resonance energy transfer (FRET) as a high-throughput assay for coupling reactions. Arylation of amines as a case study J Am Chem Soc 125 2003 6977 6985
169. K.Q. Luo, V.C. Yu, Y. Pu, and D.C. Chang Application of the fluorescence resonance energy transfer method for studying the dynamics of caspase-3 activation during UV-induced apoptosis in living HeLa cells Biochem Biophys Res Commun 283 2001 1054 1060
170. I. Gopich, and A. Szabo Fluorophore-quencher distance correlation functions from single-molecule photon arrival trajectories J Phys Chem B 109 2005 6845 6848
171. K.H. Yusuke Niino, and Kotaro Oka Simultaneous live cell imaging using dual FRET sensors with a single excitation light PLoS ONE 4 2009 e6036